Lithera, Inc., has changed its name to Neothetics, Inc. The new name strengthens the company’s positioning as a clinical-stage, specialty pharmaceutical company developing novel therapeutics for the aesthetics market. George Mahaffey, president and CEO of Neothetics, believes the new name better identifies the company with its corporate mission to develop and commercialize innovative therapies for the rapidly growing aesthetics market.
